Has Edward Gerstenfeld, MD received payments from drug or device companies?

Yes. Drug and device makers reported $211,382 in general payments to Edward Gerstenfeld, MD across 234 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Gerstenfeld, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Gerstenfeld, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Gerstenfeld, MD

Clinical Cardiac Electrophysiology · San Francisco, CANPI 1972531788

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.5%), speaking fees and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 37.5% of the total. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$211,382in general payments, 2019–2025

Across 234 payments — averaging $903.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$79K
Adagio Medical, Inc.$39K
Abbott$33K
Biosense Webster, Inc.$19K
Medtronic$18K
Medical Device Business Services, Inc.$8K
plus $15K from 8 others

$1,295,404in research payments, 2019–2025

Across 106 payments — averaging $12,221 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$898K
Adagio Medical, Inc.$148K
Atricure, Inc.$123K
Recor Medical Inc$69K
Abbott$55K
Cardiofocus, Inc.$3K
plus $162 from 1 others

What the payments were for

Consulting fees$85,53240%
Speaking & faculty fees$58,50728%
Grants$44,39821%
Travel & lodging$13,6446%
Food & beverage$9,3024%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	62	$79,276
Adagio Medical, Inc.	2	$39,369
Abbott	66	$32,758
Biosense Webster, Inc.	42	$18,502
Medtronic(2 entities)	34	$18,252
Medical Device Business Services, Inc.	9	$8,325
Siemens Medical Solutions USA, Inc.	7	$5,800
Boehringer Ingelheim International GmbH	2	$3,864
Cardiofocus, Inc.	3	$2,775
Biotronik Inc.	2	$2,149
EBR Systems, Inc.	1	$136
Merck	1	$100
Cardiva Medical, Inc.	2	$64
Amgen	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$211,382 in reported general payments places this provider in the 90th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$231,775

Medicare patients

2,741

Services billed

5,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	290	$357,016
XareltoRivaroxaban	81	$113,408
MultaqDronedarone Hcl	66	$78,937
Dofetilide	149	$40,094
Metoprolol Succinate	219	$4,848
Propafenone Hcl ErPropafenone Hcl	21	$2,466
Flecainide Acetate	38	$1,579
Bisoprolol Fumarate	22	$865
Diltiazem 24hr Er (Cd)Diltiazem Hcl	24	$831
SotalolSotalol Hcl	39	$774
Amiodarone Hcl	29	$746
Carvedilol	24	$298
Metoprolol Tartrate	37	$276
Rosuvastatin Calcium	11	$272
Cartia XtDiltiazem Hcl	12	$241

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in San Francisco

Daniel MorinSan Francisco$265K
Henry HsiaSan Francisco$231K
Randall LeeSan Francisco$174K
Joshua MossSan Francisco$138K
Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K
Nicholas Olsonla Jolla$801K
Jonathan DukesVentura$775K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →